Alignment Healthcare, Inc. (NASDAQ:ALHC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) have been given a consensus recommendation of “Moderate Buy” by the thirteen research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have given a hold recommendation, eight have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $20.05.

ALHC has been the topic of several research reports. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. The Goldman Sachs Group restated a “buy” rating and issued a $22.00 target price on shares of Alignment Healthcare in a research note on Monday, November 3rd. JPMorgan Chase & Co. raised shares of Alignment Healthcare from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $18.00 to $20.00 in a research note on Monday. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a report on Monday. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th.

Alignment Healthcare Stock Up 0.4%

Shares of NASDAQ ALHC opened at $19.22 on Thursday. The company has a market cap of $3.85 billion, a price-to-earnings ratio of -160.17 and a beta of 1.17. Alignment Healthcare has a 12 month low of $10.18 and a 12 month high of $21.06. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99. The stock has a 50-day moving average price of $17.11 and a two-hundred day moving average price of $15.47.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The firm had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. During the same period in the prior year, the company posted ($0.14) EPS. The company’s revenue was up 43.5% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, analysts forecast that Alignment Healthcare will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, insider Hyong Kim sold 51,379 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, October 9th. The shares were sold at an average price of $17.57, for a total transaction of $902,729.03. Following the completion of the sale, the insider owned 362,333 shares of the company’s stock, valued at approximately $6,366,190.81. The trade was a 12.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Dawn Christine Maroney sold 215,662 shares of the stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares of the company’s stock, valued at $29,492,659.17. The trade was a 10.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 7,582,116 shares of company stock worth $122,276,938 over the last ninety days. Corporate insiders own 7.00% of the company’s stock.

Institutional Trading of Alignment Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Wellington Management Group LLP raised its holdings in Alignment Healthcare by 167.3% in the third quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after acquiring an additional 6,940,277 shares in the last quarter. Invesco Ltd. raised its holdings in shares of Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after buying an additional 2,294,739 shares during the last quarter. Vanguard Group Inc. lifted its position in Alignment Healthcare by 13.2% during the 1st quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after acquiring an additional 1,295,825 shares during the period. Marshall Wace LLP boosted its holdings in shares of Alignment Healthcare by 173.3% in the second quarter. Marshall Wace LLP now owns 2,039,714 shares of the company’s stock valued at $28,556,000 after acquiring an additional 1,293,416 shares in the last quarter. Finally, Voya Investment Management LLC increased its position in Alignment Healthcare by 61.0% during the 3rd quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company’s stock worth $55,775,000 after purchasing an additional 1,210,930 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.